Context Therapeutics (CNTX) Assets (2020 - 2026)
Context Therapeutics (CNTX) reported Assets of $46.13 million for Q2 2026, down 47.1% from $87.15 million a year earlier and down 21.6% from the prior quarter.
Powered by 
Analysis
Context Therapeutics (CNTX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Context Therapeutics posted Assets of $68.49 million, down 30.2% from FY2024.
- Assets has a five-year compound annual growth rate of 171.1% (FY2020 to FY2025).
- By year, Assets came in at $98.13 million in FY2024 (+510.9%), $16.06 million in FY2023 (-57.7%), $37.97 million in FY2022 (-26.0%) and $51.31 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q1 2024.
- Year over year, Assets has now declined in each of the last five quarters, with growth averaging 173.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q1 2025 (growth of 741.2%); the low point was Q1 2024 (a decline of 65.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $58.86 million (Q1 2026), $68.49 million (Q4 2025) and $79.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Context Therapeutics | 21.74 Mn | -218.72 Mn | - | 46.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.13 Mn |
| Mar 31, 2026 | 58.86 Mn |
| Dec 31, 2025 | 68.49 Mn |
| Sep 30, 2025 | 79.23 Mn |
| Jun 30, 2025 | 87.15 Mn |
| Mar 31, 2025 | 92.97 Mn |
| Dec 31, 2024 | 98.13 Mn |
| Sep 30, 2024 | 86.33 Mn |
| Jun 30, 2024 | 102.71 Mn |
| Mar 31, 2024 | 11.05 Mn |
| Dec 31, 2023 | 16.06 Mn |
| Sep 30, 2023 | 22.99 Mn |
| Jun 30, 2023 | 27.76 Mn |
| Mar 31, 2023 | 31.97 Mn |
| Dec 31, 2022 | 37.97 Mn |
| Sep 30, 2022 | 42.08 Mn |
| Jun 30, 2022 | 44.70 Mn |
| Mar 31, 2022 | 47.03 Mn |
| Dec 31, 2021 | 51.31 Mn |
| Sep 30, 2021 | 2.26 Mn |
API Access
Context Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();